|
| Status |
Public on Mar 20, 2024 |
| Title |
Serological mechanisms driving cardiotoxicity in COVID-19 |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
The aim of the study is to investigate the effects of serum from COVID-19 patients on pluripotent stem cells derived cardiomyocytes (PSC-CMs)
|
| |
|
| Overall design |
To investigate the effects of serum, PSC-CMs were treated for 4 days in the presence of serum coming from control, mild or severe COVID-19 patients.
To investigate COVID-19 specific pathways, PSC-CMs were also treated with plasma coming from ARDS patients
|
| |
|
| Contributor(s) |
Colzani M, Williams EC, Mohorianu I, Sinha S |
| Citation(s) |
38041432 |
| |
| Submission date |
Jul 05, 2022 |
| Last update date |
Mar 20, 2024 |
| Contact name |
Irina Mohorianu |
| E-mail(s) |
data-submissions@stemcells.cam.ac.uk
|
| Organization name |
University of Cambridge
|
| Department |
Wellcome-MRC Cambridge Stem Cell Institute
|
| Street address |
Puddicombe Way
|
| City |
Cambridge |
| ZIP/Postal code |
CB2 0AW |
| Country |
United Kingdom |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (27)
|
|
| Relations |
| BioProject |
PRJNA855896 |
Less...
More...